128946-72-5

Upstream product

• 128946-70-3 (1S,6S)-6-(tert-butyldiphenylsilyloxy)cyclohex-2-enol 
• 78-39-7 Triethyl orthoacetate 
• 1247869-72-2 ((1S,2S,6S)-7-oxabicyclo[4.1.0]heptan-2-yloxy)(tert-butyl)diphenylsilane 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 76358-59-3 (S)-tert-butyl(cyclohex-2-en-1-yloxy)diphenylsilane 
• 6426-26-2 (S)-cyclohex-2-en-1-ol 

Downstream Products

• 128946-76-9 [(1R,2R,3R)-3-Ethoxycarbonylmethyl-2-hydroxy-6-tetradec-(Z)-ylidene-cyclohexylsulfanyl]-acetic acid ethyl ester 
• 128946-74-7 [(1R,2R,3R)-3-Carboxymethyl-2-hydroxy-6-tetradec-(Z)-ylidene-cyclohexylsulfanyl]-acetic acid 
• 106553-77-9 ethyl (1α,4β)-4-hydroxycyclohex-2-eneacetate 

Relevant academic research and scientific papers

CONFORMATIONALLY RESTRICTED LEUKOTRIENE ANTAGONISTS. ASYMMETRIC SYNTHESIS OF SOME NOR-LEUKOTRIENE D4 ANALOGS

The enantiomeric pair of conformationally-restricted nor-LTD4 analogs 10 and 11 have been synthesized stereoselectively from (S)-2-cyclohexen-1-ol

Cyclohexanealkanoic acids

The present invention is directed to 2-hydroxy-4-alkylidenecyclohexanealkanoic acids having a mercaptoalkanoic acid substituent at the 3-position. Esters and amides corresponding to the acids referred to above are also encompassed by the present invention